23 /100
LOW RISK
Score updated Jul 13, 2026

CCAP — Crescent Capital BDC, Inc. Dilution Risk Tracker

Track CCAP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CCAP — Get alerts when the score changes →

As of July 13, 2026, Crescent Capital BDC, Inc. (CCAP) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Crescent Capital BDC, Inc. has a market capitalization of $420.41M, 36.85M shares outstanding, 90 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CCAP.
🔔 Track CCAP — Get forecast alerts →

💹 Market Data

Market Cap$420.41M
Shares Outstanding36.85M
FloatN/A
Cash$6.14M
Debt$907.13M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.0% shares (2026Q1 vs prior)
90 institutional holders · 25.49M shares
#1 Texas County & District Retirement System 5.00M shares
#2 Blackstone Inc. 4.21M shares
#3 Fidelity National Financial, Inc. 4.21M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest839.1K
Days to Cover2.9
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

8-K 8K EVENT Mar 09, 2026
5 FORM5 Feb 17, 2026
5 FORM5 Feb 17, 2026
5 FORM5 Feb 17, 2026
5 FORM5 Feb 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CCAP Shareholders

Crescent Capital BDC, Inc. (CCAP) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CCAP shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CCAP in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for CCAP alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CCAP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CCAP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CCAP
📊 CCAP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CCAP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.